Staphylococcus Aureus Skin and Soft Tissue Infections

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Medical Corps, Israel Defense Force.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Medical Corps, Israel Defense Force
ClinicalTrials.gov Identifier:
NCT01385514
First received: June 28, 2011
Last updated: March 22, 2012
Last verified: March 2012
  Purpose

The purpose of this study is to evaluate strategies to prevent Staphylococcus aureus skin and soft tissue infections in soldiers during infantry training.

This study will be conducted on three different bases among groups of male recruits to IDF training base. They will provide nasal swabs to detect Staphylococcus aureus carriage in two time points: 1. before mixing and training in confined settings, reflecting carriage acquired before entering 2. After 14-30 days. All soldiers will be under surveillance for skin infection until the end of the training program.


Condition
Staphylococcus Aureus

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluating Strategies to Prevent Staphylococcus Aureus Skin and Soft Tissue Infections in Soldiers During Infantry Training

Resource links provided by NLM:


Further study details as provided by Medical Corps, Israel Defense Force:

Biospecimen Retention:   Samples Without DNA

nasal swabs to detect Staphylococcus aureus skin infection to detect Staphylococcus aureus


Estimated Enrollment: 1050
Study Start Date: July 2011
Estimated Study Completion Date: December 2013
Groups/Cohorts
company A-Training Base No.1
company A-Training Base No.2
company A-Training Base No.3

  Eligibility

Ages Eligible for Study:   18 Years to 25 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

the population of the study will be selected from infantry training bases in the IDF

Criteria

Inclusion Criteria:

  • new recruit for a combat training unit
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01385514

Contacts
Contact: Michael Hartal, MD +972-3-7374137 Mhuerta2@gmail.com

Locations
Israel
Israeli Defense Forces Recruiting
Tel aviv, Israel
Sponsors and Collaborators
Medical Corps, Israel Defense Force
Investigators
Principal Investigator: Michael Hartal, MD International Diabetes Federation
  More Information

No publications provided

Responsible Party: Medical Corps, Israel Defense Force
ClinicalTrials.gov Identifier: NCT01385514     History of Changes
Other Study ID Numbers: 1042-2011
Study First Received: June 28, 2011
Last Updated: March 22, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Soft Tissue Infections
Infection

ClinicalTrials.gov processed this record on October 01, 2014